<code id='7EED5023E2'></code><style id='7EED5023E2'></style>
    • <acronym id='7EED5023E2'></acronym>
      <center id='7EED5023E2'><center id='7EED5023E2'><tfoot id='7EED5023E2'></tfoot></center><abbr id='7EED5023E2'><dir id='7EED5023E2'><tfoot id='7EED5023E2'></tfoot><noframes id='7EED5023E2'>

    • <optgroup id='7EED5023E2'><strike id='7EED5023E2'><sup id='7EED5023E2'></sup></strike><code id='7EED5023E2'></code></optgroup>
        1. <b id='7EED5023E2'><label id='7EED5023E2'><select id='7EED5023E2'><dt id='7EED5023E2'><span id='7EED5023E2'></span></dt></select></label></b><u id='7EED5023E2'></u>
          <i id='7EED5023E2'><strike id='7EED5023E2'><tt id='7EED5023E2'><pre id='7EED5023E2'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:582
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          With fresh data, a dynamic duo powers Eli Lilly to new heights
          With fresh data, a dynamic duo powers Eli Lilly to new heights

          EliLillyCEODavidRicks(left)andChiefScientificOfficerDanielS.SkovronskyMollyFergusonforSTATThepartner

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Parkland mass shooting to be reenacted for lawsuit

          0:49The"1200building"atMarjoryStonemanDouglasHighSchool,thecrimescenewherethe2018shootingstookplace,